Addressing Motion and Confounds Issues in Resting fMRI- Application of Multi-echo EPI Scanning
1 other identifier
observational
80
0 countries
N/A
Brief Summary
Resting state functional MRI is widely used for studying brain functional networks. However, in-scanner head movement and other non-neuronal noise can disproportionately bias connectivity estimates, despite various preprocessing efforts. To address these issues, the technique combining data acquisition with multiecho (ME) echo planar imaging and analysis with spatial independent component analysis (ICA), called ME-ICA, has been develop to distinguish BOLD (neuronal) and non-BOLD (artifactual) components based on linear echo-time dependence of signals, and has been demonstrated to successfully remove non-neuronal confounds. Nonetheless, such research approach has never been applied in psychiatric populations. The study aims to fill in the gap as shown in the following.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 22, 2016
CompletedFirst Posted
Study publicly available on registry
March 28, 2016
CompletedMarch 28, 2016
March 1, 2016
11 months
March 22, 2016
March 25, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Psychiatric Interview
Subjects will be interviewed by Chinese Version of the Kiddie Epidemiologic version of the Schedule for Affective Disorders and Schizophrenia (K-SADS-E)
1 hour
Study Arms (2)
ADHD group
Subjects with clinical diagnosis of ADHD according to the DSM-IV criteria
TD group
Typically development controls without lifetime diagnosis with ADHD
Eligibility Criteria
The sample consists of 40 adults with ADHD and 40 age-, sex-matched healthy volunteers.
You may qualify if:
- \. Subjects who have clinical diagnosis of a ADHD according to the DSM-IV and DSM-5 diagnostic criteria
You may not qualify if:
- Systemic medical illness
- Current symptoms or lifetime history of DSM-5 diagnosis of mood disorder, any psychotic disorder, substance use disorder, learning disability, pervasive developmental disorder, claustrophobia, obsessive compulsive disorder, or mental retardation.
- With neurodegenerative disorder, epilepsy, involuntary movement disorder, congenital metabolic disorder, brain tumor, history of severe head trauma, and history of craniotomy;
- Full-scale IQ \< 80.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hsiang-Yuan Lin, MD
Dept of Psychiatry, National Taiwan University Hospital
- STUDY DIRECTOR
Susan Shur-Fen Gau, MD, PhD
National Taiwan University Hospital & College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2016
First Posted
March 28, 2016
Study Start
January 1, 2015
Primary Completion
December 1, 2015
Last Updated
March 28, 2016
Record last verified: 2016-03